80_FR_63772 80 FR 63570 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings

80 FR 63570 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 202 (October 20, 2015)

Page Range63570-63571
FR Document2015-26563

Federal Register, Volume 80 Issue 202 (Tuesday, October 20, 2015) 
[Federal Register Volume 80, Number 202 (Tuesday, October 20, 2015)]
[Notices]
[Pages 63570-63571]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-26563]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel.
    Date: November 3, 2015.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Democracy Blvd., 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Yin Liu, Ph.D., MD, Scientific Review Officer 
Scientific Review Branch National Institute of Arthritis, and 
Musculoskeletal and Skin Diseases, National Institute of Health 
Bethesda, MD 20892, 301-496-0505, [email protected].
    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel.

[[Page 63571]]

    Date: November 4, 2015.
    Time: 9:00 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Democracy Blvd., 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Yin Liu, Ph.D., MD, Scientific Review Officer 
Scientific Review Branch National Institute of Arthritis, and 
Musculoskeletal and Skin Diseases National Institute of Health 
Bethesda, MD 20892, 301-496-0505, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: October 14, 2015.
Melanie J. Gray,
 Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-26563 Filed 10-19-15; 8:45 am]
 BILLING CODE 4140-01-P

63570 Federal Register / Vol. 80, No. 202 / Tuesday, October 20, 2015 / Notices • Advancement of Open Science—To patents that cover them) in their Entry, otherwise. By participating in this what extent does the proposal/prototype unless the Solver chooses an open Challenge, each Solver agrees to advance the goals of open science in license for the Entry. By participating in indemnify the federal government and biomedical/health research, and fulfill the Challenge each Solver grants to the the Capital Consulting Corporation the goals of openness in terms of the U.S. government a nonexclusive, non- against third party claims for damages product and way of working? To what transferrable, irrevocable, paid-up arising from or related to Challenge extent would it move the field forward? license to practice or have practiced for activities. • Impact—What level of impact and or on behalf of the United States any Insurance benefit could the proposal—if invention throughout the world owned successful—deliver to the research or controlled by the Solver that covers Based on the subject matter of the enterprise and health research? Does the the Entry, and grants to the U.S. Challenge, the type of work that it will proposal/prototype address government and others acting on behalf possibly require, as well as an analysis implementation in multiple settings in a of the U.S. government, a royalty-free, of the likelihood of any claims for death, cross-national manner? irrevocable, non-exclusive worldwide bodily injury, or property damage, or • Innovation—What level of license to use, reproduce, and display loss potentially resulting from creativity and technological innovation publicly all parts of the Entry for the competition participation, Solvers are does the entrant demonstrate? purposes of the Challenge. This license not required to obtain liability insurance • Originality—Is the technology or includes without limitation posting or or demonstrate financial responsibility service genuinely novel and targeting an linking to the Entry on the official in order to participate in this Challenge. unmet need? Has the applicant Challenge Web site and, except for Dated: September 28, 2015. evaluated other existing or alternative object code or source code, making the Lawrence A. Tabak, approaches, or delineated their Entry available for research use by the Deputy Director, National Institutes of Health. approach in comparison to existing public. Notwithstanding the above and [FR Doc. 2015–26392 Filed 10–19–15; 8:45 am] approaches (if applicable)? consistent with the principal objective • Technological viability—Is the of the challenge to make results widely BILLING CODE 4140–01–P approach proposed viable? Can the available to the public, the NIH proposed technology deliver? encourages the Solver to distribute any DEPARTMENT OF HEALTH AND • Resource feasibility—Does the team computer code (object code and HUMAN SERVICES have the required skills and resources? preferably also source code) that is part Judges will rate each entry on five- of the Entry to the public under a liberal National Institutes of Health point scale from Not-fundable (1) to open source license that permits the Outstanding (5). The NIH and WT will public to benefit from and improve National Institute of Arthritis and hold separate judging panels, and then upon the Entry (see the licenses Musculoskeletal and Skin Diseases; will discuss priorities for selection of available at http://opensource.org/ Notice of Closed Meetings the respective winners (in Phase I), and licenses/). The Solver should include in the final winner (in Phase II). Pursuant to section 10(d) of the its submission a description of how and For Phase II, public voting will select Federal Advisory Committee Act, as under what license terms it intends to the top 3 prototypes of the 6 Phase I amended (5 U.S.C. App.), notice is make any computer code that is part of finalist, followed by a review of the hereby given of the following meetings. the Entry available to the public. prototypes for feasibility and technical The meetings will be closed to the Solvers are free to discuss their Entry merit by external advisors with and the ideas or technologies that it public in accordance with the expertise in Open Science. Prototypes contains with other parties, encouraged provisions set forth in sections will then be scored by Judges using the to share ideas/technologies publicly, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., initial Phase I criteria. and are free to contract with any third as amended. The grant applications and parties, as long as they do not sign any the discussions could disclose Intellectual Property confidential trade secrets or commercial agreement or undertake any obligation By submitting an Entry, each Solver that conflicts with the Challenge rules property such as patentable material, warrants that he or she is the sole author set forth herein. For the purpose of and personal information concerning and owner of any copyrightable works clarity, Solvers acknowledge that the individuals associated with the grant that the Entry comprises (or has intent of the Challenge is to encourage applications, the disclosure of which obtained sufficient rights in any people to collaborate and share ideas would constitute a clearly unwarranted copyrightable works owned by third and innovations. invasion of personal privacy. parties to satisfy its obligations set forth Name of Committee: National Institute of herein), that the works are wholly Liability and Indemnification Arthritis and Musculoskeletal and Skin original with the Solver (or is an By participating in this Challenge, Diseases Special Emphasis Panel. improved version of an existing work each Solver agrees to assume any and all Date: November 3, 2015. that the Solver has sufficient rights to risks and waive claims against the U.S. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant use and improve), and that the Entry federal government and its related applications. does not infringe any copyright or any entities (as defined in the COMPETES Place: National Institutes of Health, 6701 other rights of any third party of which Act), including Capital Consulting Democracy Blvd., Bethesda, MD 20892, Solver is aware. Corporation, the Challenge Expert (Virtual Meeting). mstockstill on DSK4VPTVN1PROD with NOTICES To receive an award, Solvers will not Science Advisors and Judges, except in Contact Person: Yin Liu, Ph.D., MD, be required to transfer their intellectual the case of willful misconduct, for any Scientific Review Officer Scientific Review property rights to the NIH or the injury, death, damage, or loss of Branch National Institute of Arthritis, and Challenge Partners. Each Solver retains property, revenue, or profits, whether Musculoskeletal and Skin Diseases, National Institute of Health Bethesda, MD 20892, 301– title to their Entry, including object and direct, indirect, or consequential, arising 496–0505, liuy@mail.nih.gov. source code, and expressly reserves all from participation in this Challenge, Name of Committee: National Institute of intellectual property rights (e.g., whether the injury, death, damage, or Arthritis and Musculoskeletal and Skin copyrights and rights to inventions and loss arises through negligence or Diseases Special Emphasis Panel. VerDate Sep<11>2014 17:55 Oct 19, 2015 Jkt 238001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\20OCN1.SGM 20OCN1

Federal Register / Vol. 80, No. 202 / Tuesday, October 20, 2015 / Notices 63571 Date: November 4, 2015. Federal Register on September 18, 2015, Time: 12:00 p.m. to 4:00 p.m. Time: 9:00 a.m. to 1:30 p.m. 80 FRN 56474. Agenda: To review and evaluate grant Agenda: To review and evaluate grant This meeting is being amended to add applications. applications. a panel name. The panel name is Place: National Institutes of Health, Room Place: National Institutes of Health, 6701 4F100, 5601 Fishers Lane, Rockville, MD Democracy Blvd., Bethesda, MD 20892, ‘‘Career Award.’’ The meeting is closed 20892, (Telephone Conference Call). (Virtual Meeting). to the public. Contact Person: Kelly Y. Poe, Ph.D., Contact Person: Yin Liu, Ph.D., MD, Dated: October 14, 2015. Scientific Review Officer, Scientific Review Scientific Review Officer Scientific Review Carolyn A. Baum, Program, Division of Extramural Activities, Branch National Institute of Arthritis, and Room 3F40B, National Institutes of Health, Program Analyst, Office of Federal Advisory Musculoskeletal and Skin Diseases National NIAID, 5601 Fishers Lane, MSC 9823, Committee Policy. Institute of Health Bethesda, MD 20892, 301– Bethesda, MD 20892–9823, (240) 669–5036, 496–0505, liuy@mail.nih.gov. [FR Doc. 2015–26561 Filed 10–19–15; 8:45 am] poeky@mail.nih.gov. (Catalogue of Federal Domestic Assistance BILLING CODE 4140–01–P (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Program Nos. 93.855, Allergy, Immunology, Musculoskeletal and Skin Diseases Research, and Transplantation Research; 93.856, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND Microbiology and Infectious Diseases Dated: October 14, 2015. HUMAN SERVICES Research, National Institutes of Health, HHS) Melanie J. Gray, National Institutes of Health Dated: October 14, 2015. Program Analyst, Office of Federal Advisory Michelle Trout, Committee Policy. National Institute of Allergy and Program Analyst, Office of Federal Advisory [FR Doc. 2015–26563 Filed 10–19–15; 8:45 am] Infectious Diseases; Notice of Closed Committee Policy. BILLING CODE 4140–01–P Meetings [FR Doc. 2015–26555 Filed 10–19–15; 8:45 am] BILLING CODE 4140–01–P Pursuant to section 10(d) of the DEPARTMENT OF HEALTH AND Federal Advisory Committee Act, as HUMAN SERVICES amended (5 U.S.C. App.), notice is DEPARTMENT OF HEALTH AND hereby given of the following meetings. The meetings will be closed to the HUMAN SERVICES National Institutes of Health public in accordance with the National Institutes of Health National Institute of Mental Health; provisions set forth in sections Amended Notice of Meeting 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Heart, Lung, and Blood as amended. The grant applications and Institute; Notice of Closed Meeting Notice is hereby given of a change in the discussions could disclose the meeting of the National Institute of confidential trade secrets or commercial Pursuant to section 10(d) of the Mental Health Special Emphasis Panel, property such as patentable material, Federal Advisory Committee Act, as October 26, 2015, 01:30 p.m. to October and personal information concerning amended (5 U.S.C. App.), notice is 26, 2015, 05:00 p.m., National Institutes individuals associated with the grant hereby given of the following meeting. of Health, Neuroscience Center, 6001 applications, the disclosure of which The meeting will be closed to the Executive Boulevard, Rockville, MD would constitute a clearly unwarranted public in accordance with the 20852 which was published in the invasion of personal privacy. provisions set forth in sections Federal Register on September 28, 2015, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 80 FR 58272. Name of Committee: Microbiology, as amended. The grant applications and This meeting is being amended to add Infectious Diseases and AIDS Initial Review the discussions could disclose Group; Acquired Immunodeficiency a panel name. The panel name is confidential trade secrets or commercial Syndrome Research Review Committee. ‘‘Fellowships and Dissertation Grants.’’ Date: November 9–10, 2015. property such as patentable material, The meeting is closed to the public. Time: November 9, 2015, 8:00 a.m. to 5:00 and personal information concerning Dated: October 14, 2015. p.m. individuals associated with the grant Agenda: To review and evaluate grant applications, the disclosure of which Carolyn A. Baum, applications. would constitute a clearly unwarranted Program Analyst, Office of Federal Advisory Place: National Institutes of Health, Room Committee Policy. invasion of personal privacy. 3F100, 5601 Fishers Lane, Rockville, MD [FR Doc. 2015–26560 Filed 10–19–15; 8:45 am] 20892, (Telephone Conference Call). Name of Committee: Heart, Lung, and BILLING CODE 4140–01–P Time: November 10, 2015, 8:00 a.m. to 5:00 Blood Initial Review Group; NHLBI p.m. Mentored Transition to Independence Agenda: To review and evaluate grant Review Committee. applications. Date: November 5–6, 2015. DEPARTMENT OF HEALTH AND Place: National Institutes of Health, Room Time: 8:00 a.m. to 5:00 p.m. HUMAN SERVICES 8F100, 5601 Fishers Lane, Rockville, MD Agenda: To review and evaluate grant 20892, (Telephone Conference Call). applications. National Institutes of Health Contact Person: Brenda L. Fredericksen, Place: The William F. Bolger Center, 9600 Ph.D., Scientific Review Officer, Scientific Newbridge Drive, Potomac, MD 20854. National Institute of Mental Health; Review Program, Division of Extramural Contact Person: Giuseppe Pintucci, Ph.D., Amended Notice of Meeting Activities, Room #3G22A, National Institutes Scientific Review Officer, Office of Scientific of Health/NIAID, 5601 Fishers Lane, MSC Review/DERA National Heart, Lung, and mstockstill on DSK4VPTVN1PROD with NOTICES Notice is hereby given of a change in 9823, Bethesda, MD 20892–9823, (240) 669– Blood Institute, 6701 Rockledge Drive, Room the meeting of the National Institute of 7192, Bethesda, MD 20892, 301–435–0287, 5052, brenda.fredericksen@nih.gov. Mental Health Special Emphasis Panel, Pintuccig@nhlbi.nih.gov. Name of Committee: National Institute of October 14, 2015, 3:00 p.m. to October Allergy and Infectious Diseases Special (Catalogue of Federal Domestic Assistance 14, 2015, 5:00 p.m., National Institutes Emphasis Panel; Limited Competition: Program Nos. 93.233, National Center for of Health, Neuroscience Center, 6001 International Epidemiology Databases to Sleep Disorders Research; 93.837, Heart and Executive Boulevard, Rockville, MD Evaluate AIDS (IeDEA) (U01). Vascular Diseases Research; 93.838, Lung 20852 which was published in the Date: November 16–17, 2015. Diseases Research; 93.839, Blood Diseases VerDate Sep<11>2014 17:55 Oct 19, 2015 Jkt 238001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\20OCN1.SGM 20OCN1


Document Created: 2015-12-14 15:25:49
Document Modified: 2015-12-14 15:25:49
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 3, 2015.
FR Citation80 FR 63570 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR